Latest update:
  • 1

    China's Aesthetic Medicine Body Contouring Industry

    In 2020, the market size of China's aesthetic medicine and body contouring industry was 15.05 billion RMB and will reach 41.78 billion RMB in 2025, with a CAGR of 22.7%. Its main growth momentum arises from people’s changing concept of beauty, as well as increasing acceptance and penetration rate of medical beauty. This report will mainly explore the current market for medical aesthetic body contouring, the key driver for its growth and beauty-seekers' attitude toward this new service.

  • 2

    Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital

    The investors have a partiality for the projects which could meet clinical needs, possess cutting-edge innovation technology and a talented team.

  • 3

    BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious

    BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.

  • 4

    WIA2020 | 30 Tech Entrepreneurs in China

    This research includes 150 entrepreneurs who operate the most promising technology-based businesses in China. The candidates have been selected based on five distinct categories, including professional background and business achievements. The report is a helpful resource for institutional investors seeking groundbreaking businesses in China, as well as for international corporations that are looking for partnerships in the local market.

Trending

Price

42.65 HK -4.1(-8.77%)

Innovent

01801:HKEX

Price

34.05 HK -2.95(-7.97%)

JD Health

06618:HKEX

Price

62.20 HK -5(-7.44%)

Hualan Vaccine

301207:SZSE

Price

58.78 RMB 3.98(+7.26%)

Ali Health

00241:HKEX

Price

5.48 HK -0.28(-4.86%)

Autek

300595:SZSE

Price

55.40 RMB 2.15(+4.04%)

BeiGene

06160:HKEX

Price

100.20 HK -4.1(-3.93%)

CSPC

01093:HKEX

Price

7.63 HK -0.27(-3.42%)

Hygeia

06078:HKEX

Price

51.45 HK -1.75(-3.29%)

Huahaipharm

600521:SSE

Price

22.08 RMB 0.7(+3.27%)

WuXi Biologics

02269:HKEX

Price

72.65 HK -2.4(-3.2%)

Price

4.69 HK -0.14(-2.9%)

Meinian Onehealth

002044:SZSE

Price

5.48 RMB 0.15(+2.81%)

Autobio

603658:SSE

Price

48.77 RMB 1.31(+2.76%)

Tong Ren Tang

03613:HKEX

Price

12.52 HK -0.32(-2.49%)

Dashenlin

603233:SSE

Price

30.79 RMB 0.73(+2.43%)

Wantai

603392:SSE

Price

153.71 RMB 3.56(+2.37%)

Kangtai Bio

300601:SZSE

Price

44.18 RMB 1.02(+2.36%)

Snibe Diagnostic

300832:SZSE

Price

44.50 RMB 1.02(+2.35%)

Team
Ang Gao

Ang Gao

Managing Director

Contact

Yongsheng Liang

Yongsheng Liang

Director (Healthcare BU)

Contact

Cong Liu

Cong Liu

Chief Editor (Healthcare BU)

Contact

Qiong Tao

Qiong Tao

Associate Director of BD

Contact